Sugi Predict

Sugi Predict / Targets / HNRNPA0

HNRNPA0

Heterogeneous nuclear ribonucleoprotein A0 · Q13151 · HNRNPA0 on Sugi Atlas →

0 patent compounds predicted against HNRNPA0, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPA0 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Preventive Approach to Congenital Heart Block With Hydroxychloroquine PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
ADAR1 Expression Level in Rectal Cancer nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis nanRECRUITING
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
International PPB/DICER1 Registry nanRECRUITING
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Hippotherapy in Children With Spinal Muscular Atrophy nanRECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HNRNPA0 binder may also engage these)

ProteinNameSimilarity
Q9CX86 — 1.000 Q9CX86 →
Q5RBU8 — 1.000 Q5RBU8 →
A7VJC2 — 0.999 A7VJC2 →
Q22037 — 0.997 Q22037 →
Q32P51 — 0.997 Q32P51 →
Q28521 — 0.997 Q28521 →
HNRNPA3 Heterogeneous nuclear ribonucleoprotein A3 0.996 landscape →
P51990 — 0.995 P51990 →
P51989 — 0.995 P51989 →
Q8BG05 — 0.995 Q8BG05 →
P51992 — 0.994 P51992 →
P17130 — 0.994 P17130 →
P21522 — 0.994 P21522 →
Q9TTV2 — 0.993 Q9TTV2 →
Q6URK4 — 0.993 Q6URK4 →
P49312 — 0.992 P49312 →
HNRNPA2B1 Heterogeneous nuclear ribonucleoproteins A2/B1 0.992 landscape →
O88569 — 0.991 O88569 →
Q2HJ60 — 0.991 Q2HJ60 →
P51968 — 0.990 P51968 →
Q5ZI72 — 0.990 Q5ZI72 →
A0A2R8Y4L2 — 0.989 A0A2R8Y4L2 →
HNRNPA1 Heterogeneous nuclear ribonucleoprotein A1 0.989 landscape →
Q3SWU3 — 0.989 Q3SWU3 →
RBM3 RNA-binding protein 3 0.989 landscape →
Q9Z130 — 0.989 Q9Z130 →
Q925G0 — 0.987 Q925G0 →
Q7TMK9 — 0.987 Q7TMK9 →
Q9FZ84 — 0.986 Q9FZ84 →
HNRNPAB Heterogeneous nuclear ribonucleoprotein A/B 0.986 landscape →